Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure - PubMed (original) (raw)

Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure

Andrea D Eckhart et al. Mol Pharmacol. 2002 Apr.

Abstract

Cardiovascular regulation is tightly controlled by signaling through G protein-coupled receptors (GPCRs). beta-Adrenergic receptors (ARs) are GPCRs that regulate inotropy and chronotropy in the heart and mediate vasodilation, which critically influences systemic vascular resistance. GPCR kinases (GRKs), including GRK2 (or betaARK1), phosphorylate and desensitize agonist-activated betaARs. Myocardial GRK2 levels are increased in heart failure and data suggest that vascular levels may also be elevated in hypertension. Therefore, we generated transgenic mice with vascular smooth muscle (VSM) targeted overexpression of GRK2, using a portion of the SM22alpha promoter, to determine its impact on vascular betaAR regulation. VSM betaAR signaling, as determined by adenylyl cyclase and mitogen-activated protein (MAP) kinase activation assays, was attenuated when GRK2 was overexpressed 2- to 3-fold. In vivo vasodilation in response to betaAR stimulation using isoproterenol was attenuated and conscious resting mean arterial blood pressure was elevated from 96 +/- 2 mm Hg in nontransgenic littermate control (NLC) mice (n = 9) to 112 +/- 3 mm Hg and 117 +/- 2 mm Hg in two different lines of SM22alpha-GRK2 transgenic mice (n = 7 and n = 5, respectively; p < 0.05). Interestingly, medial VSM thickness was increased 30% from 29.8 +/- 1.6 microm in NLC mice (n = 6) to 39.4 +/- 1.6 microm in SM22alpha-GRK2 mice (n = 7) (p < 0.05) and vascular GRK2 overexpression was sufficient to cause cardiac hypertrophy. These data indicate that we have developed a unique mouse model of hypertension, providing insight into the contribution that vascular betaAR signaling makes toward resting blood pressure and overall cardiovascular regulation. Moreover, they suggest that GRK2 plays an important role in vascular control and may represent a novel therapeutic target for hypertension.

PubMed Disclaimer

Cited by

Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.
Harris RC. Harris RC. Curr Opin Nephrol Hypertens. 2012 Jan;21(1):61-5. doi: 10.1097/MNH.0b013e32834de2cb. Curr Opin Nephrol Hypertens. 2012. PMID: 22123211 Free PMC article. Review.
Progress towards a public chemogenomic set for protein kinases and a call for contributions.
Drewry DH, Wells CI, Andrews DM, Angell R, Al-Ali H, Axtman AD, Capuzzi SJ, Elkins JM, Ettmayer P, Frederiksen M, Gileadi O, Gray N, Hooper A, Knapp S, Laufer S, Luecking U, Michaelides M, Müller S, Muratov E, Denny RA, Saikatendu KS, Treiber DK, Zuercher WJ, Willson TM. Drewry DH, et al. PLoS One. 2017 Aug 2;12(8):e0181585. doi: 10.1371/journal.pone.0181585. eCollection 2017. PLoS One. 2017. PMID: 28767711 Free PMC article.
The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart.
Abd Alla J, Quitterer U. Abd Alla J, et al. Cells. 2022 Feb 14;11(4):654. doi: 10.3390/cells11040654. Cells. 2022. PMID: 35203304 Free PMC article. Review.
The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of epithelial Na+ channels.
Dinudom A, Fotia AB, Lefkowitz RJ, Young JA, Kumar S, Cook DI. Dinudom A, et al. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11886-90. doi: 10.1073/pnas.0402178101. Epub 2004 Jul 29. Proc Natl Acad Sci U S A. 2004. PMID: 15284439 Free PMC article.
Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly.
Schutzer WE, Mader SL. Schutzer WE, et al. Int J Hypertens. 2012;2012:915057. doi: 10.1155/2012/915057. Epub 2011 Sep 22. Int J Hypertens. 2012. PMID: 21961055 Free PMC article.

Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure - PubMed (original) (raw)